Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The history adds Active, not recruiting status and updates to Contacts/Locations, Study Design, Study Status, and Recruitment Status, along with a new revision entry (v3.4.3) dated 2026-03-06; the prior Recruiting status was removed (2025-10-09, v3.4.2).
    Difference
    0.7%
    Check dated 2026-03-12T02:13:53.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.4.2, was added. The notice about government funding lapse (Revision: v3.4.1) was removed.
    Difference
    0.6%
    Check dated 2026-02-11T11:43:57.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new funding notice was added and the page revision was updated to v3.4.1 (replacing v3.4.0); these are administrative updates that do not affect study details.
    Difference
    0.6%
    Check dated 2026-02-04T10:26:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI changes to the history page include color-coded diffs (green additions, red deletions with strikethroughs), a glossary toggle, and an updated revision label (v3.4.0) plus a No FEAR Act Data label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-28T05:56:45.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The revision history now shows a new version v3.3.4 and removes v3.3.3, reflecting routine version control for the page, and it does not affect the study content or current record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:54:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    New revision entry v3.3.3 was added to the history, and HHS Vulnerability Disclosure and revision v3.3.2 were removed in the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T17:16:28.000Z thumbnail image

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.